StockWatch
·
Pharmaceuticals
Board Meeting11 Aug 2026, 09:00 pm

Wanbury Ltd Board Approves Un-audited Q1 FY27 Results, ESOP Allotment

AI Summary

Wanbury Ltd announced the outcome of its Board Meeting held on August 11, 2026. The Board approved the Un-audited Financial Results for the first quarter and three months ended June 30, 2026. Additionally, the company approved the allotment of 27,530 equity shares under the Wanbury Limited Employee Stock Option Plan 2016. The paid-up share capital will increase following this allotment. The Board also approved the re-appointment of Mr. Mohan Kumar Rayana as Whole-time Director for a term of five years, effective August 21, 2026, subject to member and regulatory approvals.

Key Highlights

  • Approved Un-audited Financial Results for Q1 FY27.
  • Allotted 27,530 equity shares under ESOP 2016.
  • Re-appointed Mr. Mohan Kumar Rayana as Whole-time Director.
  • Director's term is for five years, effective August 21, 2026.
  • Share capital to increase post ESOP allotment.